Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Operating Expenses (2020 - 2025)

Biofrontera has reported Operating Expenses over the past 6 years, most recently at $12.5 million for Q4 2025.

  • Quarterly results put Operating Expenses at $12.5 million for Q4 2025, down 12.12% from a year ago — trailing twelve months through Dec 2025 was $53.1 million (down 2.72% YoY), and the annual figure for FY2025 was $53.1 million, down 2.71%.
  • Operating Expenses for Q4 2025 was $12.5 million at Biofrontera, down from $13.3 million in the prior quarter.
  • Over the last five years, Operating Expenses for BFRIW hit a ceiling of $20.4 million in Q3 2021 and a floor of $8.0 million in Q3 2022.
  • Median Operating Expenses over the past 5 years was $13.3 million (2024), compared with a mean of $13.0 million.
  • Biggest five-year swings in Operating Expenses: surged 265.24% in 2021 and later crashed 61.05% in 2022.
  • Biofrontera's Operating Expenses stood at $11.0 million in 2021, then skyrocketed by 42.69% to $15.8 million in 2022, then fell by 8.27% to $14.5 million in 2023, then fell by 1.31% to $14.3 million in 2024, then decreased by 12.12% to $12.5 million in 2025.
  • The last three reported values for Operating Expenses were $12.5 million (Q4 2025), $13.3 million (Q3 2025), and $14.1 million (Q2 2025) per Business Quant data.